PTC Inc. PTC 深 沪
交易中 03-31 09:58:17 美东时间
139.80
+0.140
+0.10%
华盛通- 最 高140.75
- 今 开140.75
- 成交量 1.24万股
- 最 低 139.38
- 昨 收 139.66
- 总市值 166.36亿
- 52周最高 219.69
- 市盈率 静 23.00
- 换手率 0.01%
- 52周最低 137.50
- 委 比 -51.72%
- 总股本 1.19亿
- 历史最高 219.69
- 量 比 0.31
- 振 幅 0.98%
- 历史最低 14.25
- 每 手 1
- 风险率 21.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元
今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元
03-24 10:07
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Keybanc Maintains Overweight on PTC, Lowers Price Target to $195
Keybanc analyst Jason Celino maintains PTC (NASDAQ:PTC) with a Overweight and lowers the price target from $210 to $195.
03-17 21:36
PTC Launches Robotics Design-To-Simulation Workflow With Nvidia
PTC (NASDAQ: PTC) today announced a new robotics design-to-simulation workflow that connects PTC's cloud-native Onshape® computer-aided design (CAD) and product data management (PDM) platform with NVIDIA Isaac
03-17 20:38
财报速睇 | PTC Inc. 2026财年Q2营收7.15亿美元，同比下降3.4%；归母净利润5.21亿美元，同比增长183.2%
华盛资讯3月16日讯，PTC Inc.公布2026财年Q2业绩，公司Q2营收7.15亿美元，同比下降3.4%，归母净利润5.21亿美元，同比增长183.2%。
03-16 20:49
PTC Inc. published an investor update call presentation with FY26 guidance and USD 850 million free cash flow outlook
PTC Inc. published an investor update call presentation with FY26 guidance and USD 850 million free cash flow outlook PTC issued FY’26 guidance for constant currency ARR growth excluding Kepware and ThingWorx of 7.5% to 9.5%. FY’26 revenue guidance excluding Kepware and ThingWorx was set at USD 2.54
03-16 20:36
PTC cuts FY26 revenue outlook to USD 2.54-2.81 billion after divestiture
PTC cuts FY26 revenue outlook to USD 2.54-2.81 billion after divestiture PTC updated its FY’26 outlook to reflect the divestiture of Kepware and ThingWorx, maintaining constant-currency ARR growth guidance of 7.5% to 9.5%. FY’26 guidance excluding those businesses includes revenue of USD 2.54 billio
03-16 20:32
PTC completes sale of Kepware and ThingWorx to TPG for USD 523 million
PTC completes sale of Kepware and ThingWorx to TPG for USD 523 million PTC completed the sale of its Kepware industrial connectivity business and ThingWorx IoT business to TPG. Cash proceeds at closing were USD 523 million, reflecting USD 42 million of closing adjustments related to working capital
03-16 20:31
PTC Will Participate in Upcoming Investor Conferences
BOSTON, Feb. 27, 2026 /PRNewswire/ -- PTC (Nasdaq: PTC) today announced that it will participate in the following conferences. What: KeyBanc Capital Markets Emerging Technology Summit When: ...
02-28 05:01
